Cite

HARVARD Citation

    Gambardella, A. et al. (2023). Treatment of moderate‐to‐severe plaque psoriasis with tildrakizumab in the real‐life setting. JEADV clinical practice. 2 (1), pp. 52-58. [Online]. 
  
Back to record